shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > News > India News > Article > Covid 19 Expert panel recommends emergency use approval for Covaxin in 2 to 18 age group

Covid-19: Expert panel recommends emergency use approval for Covaxin in 2 to 18 age group

Updated on: 12 October,2021 02:14 PM IST  |  New Delhi
PTI |

'After detailed deliberation, the committee recommended grant of market authorisation of the vaccine for the age group of 2 to 18 years for restricted use in emergency situations subject to the certain conditions,' a source quoted SEC as having stated in its recommendations

Covid-19: Expert panel recommends emergency use approval for Covaxin in 2 to 18 age group

Photo for representational purpose

An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain conditions, sources said on Tuesday.


Hyderabad-based Bharat Biotech, which completed the phase 2/3 trials of Covid vaccine Covaxin for use in children aged between 2 and 18 years, had submitted the data to the Central Drugs Standard Control Organisation (CDSCO) for its verification and subsequent approval for emergency use authorisation (EUA) for the jab in the beginning of this month.


The Subject Expert Committee (SEC) on Covid-19 examined the data and deliberated on the EUA application on Monday.


"After detailed deliberation, the committee recommended grant of market authorisation of the vaccine for the age group of 2 to 18 years for restricted use in emergency situations subject to the certain conditions," a source quoted SEC as having stated in its recommendations.

The recommendations have been forwarded to the Drugs Controller General of India (DCGI) for final approval.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK